Ascendis Pharma A/S
operating company · company profileCopenhagen · 1 people tracked
Investment thesis
Ascendis Pharma employs an innovation algorithm to identify unmet medical needs where clinically validated parent drugs align with its TransCon technology platform. The company focuses on building a pipeline of therapeutic candidates primarily in endocrinology rare diseases and oncology, aiming to create therapies that meaningfully improve patient outcomes.
Source: firm website, verified Aug 6, 2026.
Team · 1 people
from public directoriesFrequently asked questions
- What sectors does Ascendis Pharma A/S focus on?
- Ascendis Pharma A/S focuses on Biotech.
- Where is Ascendis Pharma A/S located?
- Ascendis Pharma A/S is headquartered in Copenhagen, DK.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.




.jpeg)